ZERNIKEDREEF 9, LEIDEN, P7
Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement
Announces Positive Phase 1 Target Engagement
Announces Annual General Meeting Results
Announces First Quarter 2026 Operating and Financial Results
2026 Annual General Meeting of Shareholders
Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors
Announces Partnership and Formation of AI Advisory Board
Annual and Transition Report of Foreign Private Issuers
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
Registration Statement for Securities to be Offered to Employees
No filings found
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Amended Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload